CHEK2 and cancer: In this investigation, relatedness-adjusted, Bonferroni-corrected genomic ascertainment of 2 population-based, exome-sequenced, electronic health record–linked cohorts was used to quantify cancer risk and survival from P/LP germline variants in CHEK2.